Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach

18 Nov 2021

Abstract excerpt

The identification of several genetic mutations in colorectal cancer (CRC) has allowed a better comprehension of the prognosis and response to different antineoplastic treatments. Recently, through a systematic process, consensus molecular subtypes (CMS) have been described to characterize genetic and molecular mutations in CRC patients. Through CMS, CRC patients can be categorized into four molecular subtypes of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34909395
DOI: 10.5306/wjco.v12.i11.1000

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approachPMID 34909395Read ↗

Investigation of colorectal cancer in accordance with consensus molecular subtype classificationSemantic proximity Read ↗

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.Semantic proximity Read ↗

The consensus molecular subtypes of colorectal cancer.Semantic proximity Read ↗

Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.Semantic proximity Read ↗

Back to the Colorectal Cancer Consensus Molecular Subtype Future.Semantic proximity Read ↗

Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.Semantic proximity Read ↗

[Characterization of patients with sporadic colorectal cancer following the new Consensus Molecular Subtypes (CMS)].Semantic proximity Read ↗

Consensus molecular subtyping of metastatic colorectal cancer expands biomarker-directed therapeutic benefit for patients with CMS1 and CMS2 tumorsSemantic proximity Read ↗

Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo modelsSemantic proximity Read ↗

Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transitionSemantic proximity Read ↗

Analysis of Consensus Molecular Subtypes of Colorectal Cancer in Oman with Clinicopathologic Correlation.Semantic proximity Read ↗

Colorectal Cancers: An Update on Their Molecular PathologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.